About Event

Join the 5th Glioblastoma Drug Development Summit

No matter what stage you’re at, this was the go-to event for driving forward GBM drug development.

With the continued high level of unmet need for this devastating disease, the 5th Glioblastoma Drug Development Summit returned as a much-needed platform to spotlight novel scientific breakthroughs and valuable insights to bring that much-needed cure one step closer.

This unparalleled event brought together key opinion leaders from pharmaceutical giants and innovative biotechs, along with a hand-picked group of leading academics, neurosurgeons and clinical trial experts, with a clear unwavering focus on bringing much-needed glioblastoma drugs to market.

What Was New for 2024:

discover icon
insights icon
navigate icon
partner icon
funding icon

Discover novel drug targets and mechanisms of action to spark ideas for innovative new treatments and combinatorial approaches for this complex cancer

Gain insights into the very latest GBM-specific clinical trial rationale including brand new & improved response criteria and clinical endpoints, backed up by recent success stories with implementable tips for success.

Navigate the recurring barriers to success in GBM such as tumor heterogeneity and the microenvironment with data-driven actionable insights from established experts

Connect with the passionate GBM community to share ideas and form crucial partnerships with over 4 hours of dedicated networking sessions and a poster presentation slot

Tackle the renowned issue of risk-aversity in GBM funding with a powerful investor panel discussion producing practical takeaways on how to overcome this frustrating hurdle

Who Attended?

An audience of key opinion leaders in the glioblastoma space, consisting of C-level executivesdirectors, neuro-oncologists, clinicians, and scientists covering discovery through to translation and clinical development.

Graph 1
Graph 2